Find a Commonwealth Resource
Bendamustine hydrochloride
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Bendeka is a prescription intravenous chemotherapy drug containing bendamustine hydrochloride, an alkylating agent used to treat certain blood cancers like chronic lymphocytic leukemia and non-Hodgkin lymphoma. It comes as a 25 mg/mL solution in multi-dose vials, manufactured by Teva Pharmaceuticals USA, Inc. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Bendamustine hydrochloride
Access the FDA dataset for Bendamustine hydrochloride — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025